Is Valacyclovir safe?
Valacyclovir
Valacyclovir (Valtrex) has treated cold sores, genital herpes and shingles since 1995, and most people only get a headache or nausea. Serious harm is rare and mostly comes from doses too high for the kidneys, which can cause confusion, hallucinations or kidney injury in older people.
#4of 82 medications
High confidence- Brands
- Valtrex; valaciclovir in the UK and Europe; many generics
- How it works
- Turned into acyclovir in the body; stops herpes viruses copying
- Cold sores (US label)
- 2 g twice, 12 hours apart, for one day
- Shingles (US label)
- 1 g three times a day for 7 days, best within 48 hours of the rash
- Genital herpes suppression
- 500 mg or 1 g once a day
- Boxed warning
- None; severe skin reaction warning added November 2025
- US prescriptions
- About 6.9 million in 2024, ranked 103rd (ClinCalc)
- On the market
- US since June 1995
How the score breaks down
The overall score is the weighted average of these factors. Scoring rules
Serious side effects30% of score
85 out of 100, ExcellentCommon effects are mild, such as headache (14% vs 10% on placebo for cold sores) and nausea. Rare serious ones are confusion, hallucinations and kidney injury, mostly with doses too high for kidney function, and rare severe skin reactions.
Overdose margin20% of score
82 out of 100, GoodWide with healthy kidneys, narrower with weak ones. Excess acyclovir can crystallise in the kidneys. In a 2021 review of 119 neurotoxicity cases with acyclovir or valacyclovir, 83% had kidney impairment and 60% got more than the kidney-adjusted dose; most recovered within a week.
Interactions15% of score
92 out of 100, ExcellentThe 2025 Valtrex label says no clinically significant drug or food interactions are known. The main caution is other drugs that strain the kidneys, which the label says to combine carefully.
Dependence and misuse15% of score
98 out of 100, ExcellentNo dependence, misuse or Drug dependenceThe body's adaptation to a drug taken regularly, so that stopping it suddenly causes withdrawal symptoms. It is not the same as addiction.More in the glossary. Not a Controlled substanceA medicine or drug that the law restricts because it can be misused or cause dependence. Countries group them into schedules or classes.More in the glossary.
Regulatory warnings10% of score
82 out of 100, GoodNo Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary or restrictions. In November 2025 the label added a warning and ContraindicationA situation in which a medicine should not be used, because the risk clearly outweighs any benefit, such as a known allergy to it.More in the glossary for severe skin reactions (SJS, TEN, DRESS, AGEP). It also warns of TTP/HUS at 8 g a day in advanced HIV and transplant patients.
Track record10% of score
92 out of 100, ExcellentValtrex was approved in the US on 23 June 1995 (NDA 020487) and is built on acyclovir, used since the early 1980s. About 6.9 million US prescriptions in 2024; trials include the 1,484-couple transmission study (NEJM 2004).
Is valacyclovir safe?
Yes, for nearly everyone it is prescribed for. Valacyclovir, sold as Valtrex and called valaciclovir in the UK, treats cold sores, genital herpes, shingles and chickenpox. It turns into acyclovir in the body, an antiviral used since the early 1980s, and its record is long and clean. In 2024 it filled about 6.9 million US prescriptions (ClinCalc). We score it 88, close to amoxicillin (91) and among the safest medicines we rate.
The one thing that really matters is the kidneys. Valacyclovir leaves the body through them, and when they are weak, from age or disease, a normal dose can build up and cause confusion, hallucinations or kidney injury. The fix is simple: a lower dose. That makes it important for your prescriber to know your kidney function and for you to drink enough water.
What side effects are common
In the trials behind the label, side effects were mostly mild and close to placebo:
| Use | Main side effects, valacyclovir vs placebo |
|---|---|
| Cold sores (2 g twice in one day) | Headache 14% vs 10%; dizziness 2% vs 1% |
| Shingles (1 g three times a day) | Nausea 15% vs 8%; vomiting 6% vs 3% |
| Daily suppression to protect a partner | Headache 29% vs 26% |
Most people taking a short course for a cold sore or a week for shingles notice nothing at all.
Confusion, hallucinations and the kidneys
The label warns that agitation, hallucinations, confusion, seizures and a brain disorder called encephalopathy have been reported, more often in older people and in people with kidney disease given a dose too high for their kidneys. A 2021 review of 119 published cases of acyclovir or valacyclovir neurotoxicity found that 83% had kidney impairment, 57% had end-stage kidney disease, and 60% had been given more than the kidney-adjusted dose. Symptoms began after about three days on average, and three in four people recovered within a week of stopping.
Kidney injury itself is uncommon at normal doses. A study of 76,269 older Ontarians given a short course of acyclovir or valacyclovir found hospital admission for acute kidney injury in 0.27%, the same as with famciclovir, an antiviral with no known kidney toxicity. In older adults who already had chronic kidney disease, though, a 2024 Ontario study found that starting at a higher dose rather than a lower one nearly quadrupled the risk of kidney injury confirmed by blood tests (0.83% against 0.22%), although hospital visits coded for confusion or kidney injury did not clearly rise.
The label gives a dose table by kidney function. For shingles, for example, the usual 1 g three times a day falls to 1 g twice a day, once a day or 500 mg once a day as kidney function drops.
Interactions and the 2025 label change
The current Valtrex label says no clinically significant drug or food interactions are known, which is unusual and part of why it scores well. The caution is with other drugs that can strain the kidneys, and with dehydration.
In November 2025 the FDA-approved label added severe skin reactions as a warning and a ContraindicationA situation in which a medicine should not be used, because the risk clearly outweighs any benefit, such as a known allergy to it.More in the glossary: Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS and AGEP have been reported since approval. They are rare, but a painful rash with blisters or sores in the mouth or eyes means stopping the drug and getting urgent care. The label also warns of a blood clotting disorder (TTP/HUS) seen in trials of 8 g a day, many times the usual dose, in people with advanced HIV or transplants.
Who should be careful
- People over 65, and anyone with kidney disease or on dialysis: the dose must be adjusted.
- People taking other drugs that can harm the kidneys, or who are dehydrated.
- Anyone who has had a severe skin or allergic reaction to valacyclovir or acyclovir.
- People with advanced HIV or a transplant on high doses.
Start treatment early: within 72 hours of a shingles rash (best within 48), at the first tingle of a cold sore, and within a day of a genital herpes recurrence. For shingles pain that lingers, see our page on gabapentin, a common treatment for nerve pain.
How we scored it
Dependence (98), interactions (92) and track record (92) are strong. Serious side effects (85) and Overdose marginHow far a normal dose is from a harmful one. A wide margin means an accidental extra dose is unlikely to cause serious harm.More in the glossary (82) are slightly lower because the drug builds up when the kidneys are weak, causing the rare neurotoxicity and kidney cases. Regulatory warnings (82) reflects the 2025 severe skin reaction warning, with no Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary or restrictions.
Questions people ask
Is it safe to take valacyclovir every day for years?
Daily suppressive treatment for genital herpes is common and has a good safety record in people with normal kidneys. The US label notes that efficacy and safety beyond one year in people with a healthy immune system have not been formally established, so your doctor may review every year or so whether you still need it.
Does valacyclovir stop you passing on herpes?
It lowers the risk but does not remove it. In a 2004 NEJM trial of 1,484 couples, 500 mg a day cut symptomatic genital herpes in the partner from 16 cases to 4, and any new infection from 3.6% to 1.9%, over eight months. Condoms and avoiding sex during outbreaks still matter.
Can I drink alcohol with valacyclovir?
There is no known interaction between valacyclovir and alcohol, and the label lists no food or drink restrictions. Alcohol can add to dizziness and dehydration, though, and staying well hydrated helps protect the kidneys while you take it.
Can valacyclovir cause confusion or hallucinations?
Yes, rarely. It happens mostly in older people and in people with kidney disease whose dose was not lowered, and usually starts within a few days. Stop and get medical help if it happens; in a review of 119 cases most people recovered within a week once the drug was stopped.
Is valacyclovir safe in pregnancy?
The US label says several decades of data on valacyclovir and acyclovir in pregnancy have not shown a higher risk of major birth defects. The label adds that herpes caught in the third trimester passes to the baby in 30 to 50% of cases, so untreated infection carries its own risk. Talk to your midwife or doctor.
Does valacyclovir help Alzheimer's disease?
No. In the VALAD trial, published in JAMA in 2026, 120 people with early Alzheimer's and herpes antibodies took 4 g a day or placebo for 78 weeks. Memory and thinking declined more on valacyclovir, and the authors said it should not be used for Alzheimer's.
Sources
- 1.VALTREX (valacyclovir hydrochloride) caplets prescribing information (opens in a new tab) · DailyMed / GlaxoSmithKline, 2025
- 2.Once-daily valacyclovir to reduce the risk of transmission of genital herpes (opens in a new tab) · New England Journal of Medicine (Corey et al.), 2004
- 3.Risk of acute kidney injury from oral acyclovir: a population-based study (opens in a new tab) · American Journal of Kidney Diseases (Lam et al.), 2013
- 4.Higher dose antiviral therapy for herpes infections is associated with a risk of serious adverse events in older adults with chronic kidney disease (opens in a new tab) · Pharmacology Research & Perspectives, 2024
- 5.Neurotoxicity associated with acyclovir and valacyclovir: a systematic review of cases (opens in a new tab) · Journal of Clinical Pharmacy and Therapeutics (Brandariz-Nuñez et al.), 2021
- 6.Valacyclovir treatment of early symptomatic Alzheimer disease: the VALAD randomized clinical trial (opens in a new tab) · JAMA (Devanand et al.), 2026
- 7.Valacyclovir (opens in a new tab) · MedlinePlus (US National Library of Medicine), 2026
- 8.Valacyclovir drug usage statistics, United States, 2014 to 2024 (opens in a new tab) · ClinCalc DrugStats (MEPS data), 2026